286 related articles for article (PubMed ID: 24024156)
1. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies.
Weber D; Milkovic L; Bennett SJ; Griffiths HR; Zarkovic N; Grune T
Redox Biol; 2013; 1(1):226-33. PubMed ID: 24024156
[TBL] [Abstract][Full Text] [Related]
2. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
3. Measurement of 4-Hydroxynonenal (4-HNE) Protein Adducts by ELISA.
Mehta K; Patel VB
Methods Mol Biol; 2019; 1990():43-52. PubMed ID: 31148061
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates.
Borovic S; Rabuzin F; Waeg G; Zarkovic N
Free Radic Res; 2006 Aug; 40(8):809-20. PubMed ID: 17015259
[TBL] [Abstract][Full Text] [Related]
5. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
[TBL] [Abstract][Full Text] [Related]
6. Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: Increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response.
Wang G; Li H; Firoze Khan M
Free Radic Res; 2012 Dec; 46(12):1472-81. PubMed ID: 22950782
[TBL] [Abstract][Full Text] [Related]
7. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
[TBL] [Abstract][Full Text] [Related]
8. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner.
Long EK; Olson DM; Bernlohr DA
Free Radic Biol Med; 2013 Oct; 63():390-8. PubMed ID: 23726997
[TBL] [Abstract][Full Text] [Related]
9. Epitope mapping and characterization of 4-hydroxy-2-nonenal modified-human serum albumin using two different polyclonal antibodies.
Campos-Pinto I; Méndez L; Schouten J; Wilkins J; Fedorova M; Pitt AR; Davis P; Spickett CM
Free Radic Biol Med; 2019 Nov; 144():234-244. PubMed ID: 31075498
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.
Aslebagh R; Pfeffer BA; Fliesler SJ; Darie CC
Electrophoresis; 2016 Oct; 37(20):2615-2623. PubMed ID: 27184861
[TBL] [Abstract][Full Text] [Related]
11. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
12. Repair kinetics of acrolein- and (E)-4-hydroxy-2-nonenal-derived DNA adducts in human colon cell extracts.
Choudhury S; Dyba M; Pan J; Roy R; Chung FL
Mutat Res; 2013; 751-752():15-23. PubMed ID: 24113140
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes.
Uchida K; Szweda LI; Chae HZ; Stadtman ER
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8742-6. PubMed ID: 8378358
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological relevance of aldehydic protein modifications.
Zarkovic N; Cipak A; Jaganjac M; Borovic S; Zarkovic K
J Proteomics; 2013 Oct; 92():239-47. PubMed ID: 23438936
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases.
Zarkovic K; Jakovcevic A; Zarkovic N
Free Radic Biol Med; 2017 Oct; 111():110-126. PubMed ID: 27993730
[TBL] [Abstract][Full Text] [Related]
16. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
17. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct.
Toyokuni S; Miyake N; Hiai H; Hagiwara M; Kawakishi S; Osawa T; Uchida K
FEBS Lett; 1995 Feb; 359(2-3):189-91. PubMed ID: 7867796
[TBL] [Abstract][Full Text] [Related]
18. U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts.
Rohn TT; Nelson LK; Waeg G; Quinn MT
Biochem Pharmacol; 1998 Nov; 56(10):1371-9. PubMed ID: 9825737
[TBL] [Abstract][Full Text] [Related]
19. A Highly Sensitive, Reproducible Assay for Determining 4-hydroxynonenal Protein Adducts in Biological Material.
Monroe TB; Anderson EJ
Bio Protoc; 2019 Oct; 9(19):e3383. PubMed ID: 33654879
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel monoclonal antibody against 4-hydroxy-2E,6Z-dodecadienal (4-HDDE)-protein adducts: Immunochemical application in quantitative and qualitative analyses of lipid peroxidation in vitro and ex vivo.
Uchida K; Shibata T; Toyokuni S; Daniel B; Zarkovic K; Zarkovic N; Sasson S
Free Radic Biol Med; 2018 Aug; 124():12-20. PubMed ID: 29807161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
